Nanogen News (NASDAQ:NGEN)
| Latest Nanogen News Headlines | | Date | Time | Source | | | 11/01/2006 | 4:00PM | PRNUS | Nanogen Reports 2006 Third Quarter Financial Results
SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, today reported its unaudited financial results for the quarter ended September 30, 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050803/LAW135LOGO )
Total revenues for the third quarter of 2006... More...>> |
| 10/31/2006 | 8:00AM | PRNUS | Heiner Dreismann, Former Roche Executive, Joins Nanogen Board of Directors
SAN DIEGO, Oct. 31 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that Heiner Dreismann, Ph.D. has been named to its Board of Directors. Dreismann, currently CEO of FasTraQ, Inc., has more than 20 years experience with Roche in the biotech and healthcare... More...>> |
| 10/30/2006 | 8:00AM | PRNUS | Nanogen to Host Third Quarter Conference Call and Webcast on November 1, 2006
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, will host a conference call on Wednesday, November 1, 2006 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2006 third quarter financial results. The financial results press release will be issued... More...>> |
| 10/30/2006 | 8:00AM | PRNUS | Nanogen Awarded Additional Patents for Diabetes, Alzheimer's Disease Biomarkers
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it has been issued four patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimer's disease biomarkers. The current patents are the most recent... More...>> |
| 10/05/2006 | 1:30PM | PRNUS | Nanogen Announces Consolidation and Cost Reduction Actions
SAN DIEGO, Oct. 5 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it plans to reduce staff in North America by approximately 15% by the end of 2006. The reduction will be achieved through both attrition and consolidation of activities in R&D, manufacturing... More...>> |
| 10/04/2006 | 10:47AM | PRNUS | Drug Royalty Corporation Inc. Acquires Royalties from Nanogen Inc. for $20 Million
TORONTO, and SAN DIEGO, Oct. 4 /PRNewswire/ -- Drug Royalty Corporation Inc. (DRC) and Nanogen Inc. (NASDAQ:NGEN) announced today that they have entered into an agreement for a trust managed by DRC to acquire an interest in royalties on the MGB(TM) (minor groove binder) technology owned by Nanogen for 5' nuclease real-time... More...>> |
| 09/19/2006 | 7:00AM | PRNUS | IAO, DOX and NGEN Update the Investment Community in All-New Interviews With WallSt.net
NEW YORK, Sept. 19 /PRNewswire/ -- On September 14, Mark Scott, President and Chief Financial Officer of IA Global, Inc. (AMEX:IAO) updated the investment community in an all-new interview with http://www.wallst.net/ . Interview highlights include detailed discussions on the following topics:
- Increasing the company's... More...>> |
| 09/06/2006 | 8:00AM | PRNUS | New Patent Expands Nanogen's Core Nanotechnology Position
Nanofabrication and Nanomanufacturing Applications Claimed
SAN DIEGO, Sept. 6 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it has been granted United States Patent No. 7,060,224 from the U.S. Patent and Trademark Office for an application of its... More...>> |
| 08/24/2006 | 8:00AM | PRNUS | Nanogen Earns Patents for Use of Biomarkers Related to Diabetes and Alzheimers Disease
SAN DIEGO, Aug. 24 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it has been issued six patents by the U.S. Patent and Trademark Office for inventions related to diabetes and Alzheimers disease and biomarkers.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050803/LAW135LOGO)
U.S... More...>> |
| 08/23/2006 | 8:00AM | PRNUS | Nanogen Expands Point-of-Care Product Line to Include Drugs of Abuse Tests
American Bio Medica Corporation and Nanogen Sign Supply Agreement
SAN DIEGO and KINDERHOOK, N.Y., Aug. 23 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), a developer of advanced diagnostic products, and American Bio Medica Corporation (NASDAQ:ABMC), a global provider of immunoassay diagnostic test kits, announced... More...>> |
| 08/09/2006 | 4:00PM | PRNUS | Fisher HealthCare to Distribute Nanogen Real-Time PCR Products to Clinical Laboratories
SAN DIEGO, Aug. 9 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that Fisher HealthCare, Inc., a unit of Fisher Scientific International Inc. (NYSE:FSH), will become the exclusive distributor of Nanogen's MGB Alert(TM) real-time polymerase chain reaction... More...>> |
| 08/09/2006 | 4:00PM | PRNUS | Nanogen Reports 2006 Second Quarter Financial Results
SAN DIEGO, Aug. 9 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, today reported its unaudited financial results for the quarter ended June 30, 2006.
(Logo: http://www.newscom.com/cgi-bin/prnh/20050803/LAW135LOGO)
Total revenues for the second quarter of 2006 more... More...>> |
| 08/07/2006 | 8:00AM | PRNUS | Nanogen to Host Second Quarter Conference Call and Webcast on August 9, 2006
SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, will host a conference call on Wednesday, August 9, 2006 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2006 second quarter financial results. The financial results press release will be issued at... More...>> |
| 08/03/2006 | 8:00AM | PRNUS | Nanogen and Fisher Scientific Expand Molecular Diagnostics R&D Collaboration Agreement
SAN DIEGO and HAMPTON, N.H., Aug. 3 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), a developer of advanced diagnostic products, and Fisher Scientific International Inc. (NYSE:FSH) announced today that the companies have expanded their relationship to include a research and development collaboration in molecular... More...>> |
| 07/13/2006 | 8:00AM | PRNUS | Nanogen Releases New Real-Time PCR Reagents
SAN DIEGO, July 13 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it has expanded its product portfolio to include MGB Alert(TM) real-time PCR reagents designed to assist laboratories in developing tests that can detect sequences associated with... More...>> |
| 06/15/2006 | 8:00AM | PRNUS | Nanogen Releases Enterovirus Reagent Employing Newly Patented Hybridization Technology
SAN DIEGO, June 15 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it has expanded its product portfolio to include the MGB Alert(TM) ENV real-time PCR reagent, designed to detect sequences associated with enteroviruses. Prevalent in summer and fall... More...>> |
| 05/15/2006 | 8:00AM | PRNUS | Nanogen Announces Type II Diabetes Research Collaboration
SAN DIEGO, May 15 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, has announced a collaboration agreement with Oy Jurilab, Ltd., the Finnish genomics company. The collaboration is designed to identify and validate new prognostic markers for type II diabetes, one of... More...>> |
| 05/11/2006 | 4:00PM | PRNUS | Nanogen Reports 2006 First Quarter Financial Results
SAN DIEGO, May 11 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, today reported its unaudited financial results for the quarter ended March 31, 2006.
Total revenues for the first quarter of this year increased by 37 percent to $4.4 million from $3.2 million in the... More...>> |
| 05/10/2006 | 8:00AM | PRNUS | Nanogen Receives $25 Million Equity Financing Commitment
SAN DIEGO, May 10 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, announced today that it has received a commitment for up to $25 million in common stock equity financing from Azimuth Opportunity Ltd. Subject to the terms and conditions of a purchase agreement between... More...>> |
| 05/08/2006 | 8:00AM | PRNUS | Nanogen to Release First Quarter Financial Results and Host Webcast on May 11, 2006
SAN DIEGO, May 8 /PRNewswire-FirstCall/ -- Nanogen, Inc. (NASDAQ:NGEN), developer of advanced diagnostic products, will host a conference call on Thursday, May 11, 2006 at 4:30 p.m. Eastern (1:30 p.m. Pacific) to discuss 2006 first quarter financial results. The financial results press release will be issued at close... More...>> |
|
|
|